BioPlx has a total of 20 patents globally, out of which no patents have been granted. Of these 20 patents, more than 95% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of BioPlx.
BioPlx was founded in the year 2015. The Company is an advanced microbiome company that prevents infectious disease through the management of the microbiome.
Do read about some of the most popular patents of BioPlx which have been covered by us in this article and also you can find BioPlx patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over BioPlx patent portfolio.
How many patents does the founder of BioPlx have?
The founders Ravi Starzl has 0 patent and Tim Starzl has 0 patent.
How many patents does BioPlx have?
BioPlx has a total of 20 patents globally. These patents belong to 6 unique patent families. Out of 20 patents, 19 patents are active.
How Many Patents did BioPlx File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | BioPlx Applications Filed | BioPlx Patents Granted |
| 2022 | 2 | – |
| 2021 | 5 | – |
| 2020 | 7 | – |
| 2018 | 6 | – |
How many BioPlx patents are Alive/Dead?
How Many Patents did BioPlx File in Different Countries?
Countries in which BioPlx Filed Patents
| Country | Patents |
| United States Of America | 3 |
| Canada | 3 |
| Europe | 3 |
| Australia | 2 |
| Hong Kong (S.A.R.) | 2 |
| India | 1 |
| China | 1 |
| Mexico | 1 |
| Philippines | 1 |
Where are Research Centres of BioPlx Patents Located?
The Research Centre for all the BioPlx patents is the United States of America.
Best BioPlx Patents
US20190169623A1 is the most popular patent in the BioPlx portfolio. It has received 9 citations so far from companies like Phagelux, Inc., Contrafect Corporation and Grape King Bio Ltd.
Below is the list of most cited patents of BioPlx:
| Publication Number | Citation Count |
| US20190169623A1 | 9 |
| WO2019113096A1 | 2 |
| CN111918960A | 1 |
| WO2021247729A1 | 1 |
What Percentage of BioPlx US Patent Applications were Granted?
BioPlx (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of BioPlx patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for BioPlx?
| Law Firm | Total Applications | Success Rate |
| Merchant & Gould P C | 3 | 0% |
List of BioPlx Patents
| BioPlx Patents | Title |
| US20220288135A1 | Live Biotherapeutic Compositions And Methods |
| US20220025364A1 | Methods For Stable Genomic Integration In Recombinant Microorganisms |
| US20190169623A1 | Methods And Compositions To Prevent Microbial Infection |
| EP3996510A4 | Live Biotherapeutic Compositions And Methods |
| EP4158010A1 | Methods For Stable Genomic Integration In Recombinant Microorganisms |
| EP3720458A4 | Methods And Compositions To Prevent Microbial Infection |
| CN111918960A | Methods And Compositions For Preventing Microbial Infections |
| WO2021247729A1 | Methods For Stable Genomic Integration In Recombinant Microorganisms |
| WO2021007341A3 | Live Biotherapeutic Compositions And Methods |
| CA3181274A1 | Methods For Stable Genomic Integration In Recombinant Microorganisms |
| CA3146363A1 | Live Biotherapeutic Compositions And Methods |
| CA3084954A1 | Methods And Compositions To Prevent Microbial Infection |
| AU2020309551A1 | Live Biotherapeutic Compositions And Methods |
| AU2018379996A1 | Methods And Compositions To Prevent Microbial Infection |
| HK40074351A | Live Biotherapeutic Compositions And Methods |
| HK40039335A | Methods And Compositions To Prevent Microbial Infection |
| IN202037027289A | Methods And Compositions To Prevent Microbial Infection |
| MX2020005875A | Methods And Compositions To Prevent Microbial Infection |
| PH12020550941A1 | Methods And Compositions To Prevent Microbial Infection |
| WO2019113096A1 | Methods And Compositions To Prevent Microbial Infection |
What are BioPlx’ key innovation segments?
What Technologies are Covered by BioPlx?
The chart below distributes patents filed by BioPlx